ARTICLE | Company News
VLST, Novo Nordisk deal
December 22, 2008 8:00 AM UTC
The partners will use VLST's discovery platform to identify targets and biologics for autoimmune and inflammatory disorders. VLST will receive an undisclosed upfront payment and a $12 million equity i...